首页 | 本学科首页   官方微博 | 高级检索  
检索        

参芪汤在冠状动脉粥样硬化性心脏病综合康复治疗中的作用
引用本文:郑光敏,庞菲,张威,李玮,霍建敏,龚晏萱,杨建军,周国芳,李文波.参芪汤在冠状动脉粥样硬化性心脏病综合康复治疗中的作用[J].甘肃中医,2014,0(9):102-105.
作者姓名:郑光敏  庞菲  张威  李玮  霍建敏  龚晏萱  杨建军  周国芳  李文波
作者单位:郑光敏 (甘肃省第二人民医院,甘肃 兰州,730000); 庞菲 (甘肃省第二人民医院,甘肃 兰州,730000); 张威(甘肃省军区五泉山干休所); 李玮 (甘肃省第二人民医院,甘肃 兰州,730000); 霍建敏 (甘肃省第二人民医院,甘肃 兰州,730000); 龚晏萱 (甘肃省第二人民医院,甘肃 兰州,730000); 杨建军 (甘肃省第二人民医院,甘肃 兰州,730000); 周国芳 (甘肃省第二人民医院,甘肃 兰州,730000); 李文波 (甘肃省第二人民医院,甘肃 兰州,730000);
摘    要:目的:探讨参芪汤对冠心病患者康复疗效的影响。方法:将冠心病患者80例随机分为治疗组和对照组各40例,对照组予常规治疗,治疗组在对照组治疗基础上予中医辨证施治。1个月为1个疗程,2个疗程后观察疗效。结果:治疗组总有效率为82.68%较对照组的69.33%高,差异有统计学意义(P〈0.05),显效率21.22%高于对照组的7.38%,2组相比差异有统计学意义(P〈0.05);2组中医证候积分较治疗前均下降(P〈0.05),SF-36量表评分,治疗组患者在"身体疼痛""活力""情感职能""精神健康""健康变化"等维度积分方面明显高于对照组(P〈0.05);6分钟步行试验2组比较差异具有统计学意义(P〈0.05),2组左心室射血分数治疗前后比较差异具有统计学意义(P〈0.05),但2组间比较差异无统计学意义(P〉0.05)。结论:参芪汤可改善冠心病患者临床症状;改善患者心功能,提高患者的生存质量,促进术后患者的康复过程。

关 键 词:冠状动脉粥样硬化性心脏病  参芪汤  治疗  临床研究性

Clinical Study on ShenQiTang in Comprehensive Rehabilitation Scheme for Coronary Atherosclerotic Heart Disease
Institution:ZHENG Guangmin, PANG Fei, ZHANG Wei, LI Wei, HUO Jianmin, GONG Yanxuan, YANG Jianjun, ZHOU Guofang, LI Wenbo 1 Second Provincial People's Hospital of Gansu, Lanzhou 730000, China; 2 Wuquanshan Cadre Sanatorium of Gansu Provincial Military Region
Abstract:Objective: To explore the influence of ShenQiTang on the rehabilitation of the patients with coronary atherosclerotic heart disease. Methods: Eighty patients were randomized into the treatment group and the control group, 40 cases each group, the control group received routine treatment and the treatment group syndrome differentiation and treatment on the foundation of the treatment given to the control group. One month was one course of the treatment, curative effects were observed after two courses of the treatment. Results: Total effective rate of the treatment group was 82.68%, higher than 69.33% of the control group with significant difference (P〈0.05), markedly effective rate of the treatment group was 21.22%, higher than 7.38% of the control group (P〈0.05). TCM symptom scales of both groups were decreased compared with before treating (P〈0.05), SF-36 scales showed that the treatment group was obviously higher than the control group in the dimension scales including body pain, vitality, role emotional, mental health, reported health transition and others (P〈 0.05). The comparison between both groups showed statistical difference in six minute walking test (P〈0.05), the comparisons between before and after treating demonstrated statistical differences in left ventricular ejection fraction (LVEF) (P〈0.05), but there was no statistical meaning between both groups (P〉 0.05). Conclusion: ShenQiTang could improve clinical symptom of the patients with coronary heart disease, improve heart function and life quality of the patients, and promote the recovery of the patients after the surgery.
Keywords:coronary atherosclerotic heart disease  ShenQiTang  treatment  clinical study
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号